Author

Geena Skariah

University of MichiganORCID 0000-0003-3955-1769Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:proteomics· 1

Frequent Co-Authors

Peter K. ToddiD· 2 shared Amy Krans· 1 shared André Monteiro da RochaiD· 1 shared Bryana Bayly· 1 shared Caitlin M. RodrigueziD· 1 shared Gary Daniel SmithiD· 1 shared Jack M. ParentiD· 1 shared Jill M. Haenfler· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Peter K. ToddORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceActa Neuropathologica CommunicationsPeer-reviewedOct 30, 2019

Neuropathology of RAN translation proteins in Fragile X-associated Tremor/Ataxia Syndrome

Amy Krans, Geena Skariah, Yuan Zhang…·Peter K. Todd

The paper investigates RAN translation products in FXTAS brains, finding FMRpolyG accumulates in ubiquitin and p62-positive inclusions, while FMRpolyA is less abundant and less frequently co-localized.

53 citationstop 5%

humanproteomics

𝕏 PostBluesky

NeuroscienceFrontiers in Molecular NeurosciencePeer-reviewedAug 15, 2018

Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells

Jill M. Haenfler, Geena Skariah, Caitlin M. Rodriguez…·Peter K. Todd

This study reactivates FMR1 transcription in FXS patient cells using CRISPR/dCAS9 and VP192, increasing FMRP levels and demonstrating a potential therapeutic approach for Fragile X Syndrome.

57 citationstop 4%

humanexperimental assay

𝕏 PostBluesky